Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
International Journal of Hematology-Oncology and Stem Cell Research|December 20, 2024
Hematologic Parameters Cut-off Assessment of Adult Alpha-Thalassemia Patients in IranBijan Keikhaei, Saeid Bitaraf, Ladan Mafakher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 4, 2021
The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and SitagliptinAlireza Malayeri, Mehrnoosh Zakerkish, Farrokh Ramesh, et al.
Scientific Reports|December 4, 2025
Synergistic chemo-photothermal therapy using doxorubicin-loaded gold nanorods for enhanced apoptosis in lung cancer cellsGhazalsadat Mousavi Ramhormozi, Saeid Reza Khatami, Hamid Galehdari, et al.
Frontiers in Oncology|September 2, 2022
CASC11 and PVT1 spliced transcripts play an oncogenic role in colorectal carcinogenesisMina Zamani, Ali-Mohammad Foroughmand, Mohammad-Reza Hajjari, et al.
Iranian Red Crescent Medical Journal|November 13, 2014
Association of MEF2A gene polymorphisms with coronary artery diseaseAli Mohammad Foroughmand, Zahra Shahbazi, Hamid Galehdari, et al.
Iranian Biomedical Journal|May 21, 2014
Exon sequencing of PKD1 gene in an Iranian patient with autosomal-dominant polycystic kidney diseaseAtousa Hafizi, Saeid Reza Khatami, Hamid Galehdari, et al.
Iranian Biomedical Journal|March 8, 2016
The First Report of a 290-bp Deletion in β-Globin Gene in the South of IranMohammad Hamid, Ladan Dawoody Nejad, Gholamreza Shariati, et al.
Iranian Journal of Neurology|June 19, 2019
Association of human leukocyte antigen-DRB haplotype in multiple sclerosis population of Khuzestan, IranNooshin Delfan, Hamid Galehdari, Mohammad Shafiei, et al.
Ejhaem|July 18, 2022
Alpha-globin gene triplication and its effect in beta-thalassemia carrier, sickle cell trait, and healthy individualMohammad Hamid, Bijan Keikhaei, Hamid Galehdari, et al.
Molecular Biotechnology|July 17, 2025
Investigating the Efficacy of the CRISPR/Cas9 Gene-Editing System for Targeting the HBB FSC 36-37 (-T) Mutation Locus in Hematopoietic Stem CellsNasim Mayeli Fereydani, Hamid Galehdari, Elham Hoveizi, et al.
Pageof 17